|
WO1993007751A1
(en)
|
1991-10-18 |
1993-04-29 |
Monsanto Company |
Fungicides for the control of take-all disease of plants
|
|
SE9703407D0
(sv)
*
|
1997-09-19 |
1997-09-19 |
Astra Ab |
New use
|
|
SE9802073D0
(sv)
|
1998-06-11 |
1998-06-11 |
Astra Ab |
New use
|
|
GB9825554D0
(en)
*
|
1998-11-20 |
1999-01-13 |
Smithkline Beecham Spa |
Novel Compounds
|
|
US7037922B1
(en)
|
2000-03-10 |
2006-05-02 |
Neurogen Corporation |
Aryl fused 2,4-disubstituted pyridines: NK3 receptor ligands
|
|
US6413982B1
(en)
|
1999-03-29 |
2002-07-02 |
Neurogen Corporation |
4-substituted quinoline derivatives
|
|
AU4802500A
(en)
|
1999-04-26 |
2000-11-10 |
Neurogen Corporation |
2-aminoquinolinecarboxamides: neurokinin receptor ligands
|
|
JP2004525184A
(ja)
*
|
2001-04-11 |
2004-08-19 |
グラクソスミスクライン・ソシエタ・ペル・アチオニ |
Ｎｋ−３およびｎｋ−２受容体アンタゴニストとしての３−置換キノリン−４−カルボキサミド誘導体
|
|
WO2002089802A2
(en)
*
|
2001-05-08 |
2002-11-14 |
Schering Corporation |
Use of neurokinin receptor antagonists to treat androgen-dependent diseases
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
DK1911763T3
(da)
|
2003-01-28 |
2010-11-15 |
Ironwood Pharmaceuticals Inc |
Sammensætninger til behandling af mavetarmsygdomme
|
|
GB0303086D0
(en)
|
2003-02-11 |
2003-03-19 |
Merck Sharp & Dohme |
New compounds
|
|
GB0419192D0
(en)
|
2004-08-27 |
2004-09-29 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
SG155229A1
(en)
*
|
2004-11-09 |
2009-09-30 |
Smithkline Beecham Corp |
Glycogen phosphorylase inhibitor compounds and pharmaceutical compositions thereof
|
|
GB0425077D0
(en)
*
|
2004-11-12 |
2004-12-15 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0515580D0
(en)
|
2005-07-29 |
2005-09-07 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
WO2007018466A1
(en)
*
|
2005-08-11 |
2007-02-15 |
Astrazeneca Ab |
Alkylpyridyl quinolines as nk3 receptor modulators
|
|
AR057130A1
(es)
|
2005-09-21 |
2007-11-14 |
Astrazeneca Ab |
Quinolinas de alquilsulfoxido y una composicion farmaceutica
|
|
TW200804288A
(en)
|
2005-12-12 |
2008-01-16 |
Astrazeneca Ab |
Alkylsulphonamide quinolines
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
AU2008261102B2
(en)
|
2007-06-04 |
2013-11-28 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EA201000392A1
(ru)
*
|
2007-09-28 |
2010-10-29 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Соединение, представляющее собой ингибитор гликогенфосфорилазы, и его фармацевтическая композиция
|
|
CN101932557A
(zh)
*
|
2007-09-28 |
2010-12-29 |
葛兰素史密丝克莱恩有限责任公司 |
糖原磷酸化酶抑制剂化合物及其药物组合物
|
|
CA2930674A1
(en)
|
2008-06-04 |
2009-12-10 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
EP3241839B1
(en)
|
2008-07-16 |
2019-09-04 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
EP3939964A1
(en)
|
2008-12-31 |
2022-01-19 |
Ardelyx, Inc. |
Combinations for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
WO2018129556A1
(en)
|
2017-01-09 |
2018-07-12 |
Ardelyx, Inc. |
Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
US10376481B2
(en)
|
2012-08-21 |
2019-08-13 |
Ardelyx, Inc. |
Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
|
|
CN104902930A
(zh)
|
2012-08-21 |
2015-09-09 |
阿德利克斯公司 |
在治疗与液体潴留或盐分过载相关的疾病和胃肠道疾病中用于抑制nhe-介导的反向转运的化合物和方法
|
|
HK1220611A1
(zh)
|
2013-03-15 |
2017-05-12 |
Bausch Health Ireland Limited |
用於治疗胃肠道病症的组成物
|
|
EP2970384A1
(en)
|
2013-03-15 |
2016-01-20 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
CA2909169A1
(en)
|
2013-04-12 |
2014-10-16 |
Ardelyx, Inc. |
Nhe3-binding compounds and methods for inhibiting phosphate transport
|
|
EP2986293A1
(en)
|
2013-04-19 |
2016-02-24 |
Astrazeneca AB |
A nk3 receptor antagonist compound (nk3ra) for use in a method for the treatment of polycystic ovary syndrome (pcos)
|
|
SI3004138T1
(sl)
|
2013-06-05 |
2024-07-31 |
Bausch Health Ireland Limited |
Ultra čisti agonisti gvanilat ciklaze C, postopek za njihovo pripravo in uporabo
|
|
WO2017072629A1
(en)
|
2015-10-29 |
2017-05-04 |
Cadila Healthcare Limited |
Pharmaceutical combination of nk3 receptor antagonist and biguanides
|
|
EP3565811A1
(en)
|
2017-01-09 |
2019-11-13 |
Ardelyx, Inc. |
Inhibitors of nhe-mediated antiport
|
|
CN110267944B
(zh)
|
2017-01-09 |
2024-03-08 |
阿德利克斯股份有限公司 |
可用于治疗胃肠道病症的化合物
|